Johnson & Johnson
看多

JNJ - Sector rotating to health care

109
JNJ is proven to be much more of a defensive stock and has higher probability of increasing upside. ROC, DM+ and rising OBV/volume all pointing towards the upside.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。